Comment
doi: 10.1182/blood-2017-11-813006.
DNA distress creates lethal opportunity in MPN
Affiliations
- PMID: 29284611
- DOI: 10.1182/blood-2017-11-813006
Item in Clipboard
Comment
DNA distress creates lethal opportunity in MPN
Blood.
.
Free article
No abstract available
Conflict of interest statement
Conflict-of-interest disclosure: J.W.T. receives research support from Agios Pharmaceuticals, Array Biopharma, Aptose Biosciences, AstraZeneca, Constellation Pharmaceuticals, Genentech, Gilead, Incyte Corporation, Janssen Pharmaceuticals, Seattle Genetics, Syros, and Takeda Pharmaceutical Company and is a consultant for Leap Oncology.
Comment on
-
Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.Blood. 2017 Dec 28;130(26):2848-2859. doi: 10.1182/blood-2017-05-784942. Epub 2017 Oct 17. Blood. 2017. PMID: 29042365 Free PMC article.
Similar articles
-
Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):374-81. doi: 10.1177/1076029612453761. Epub 2012 Jul 23. Clin Appl Thromb Hemost. 2013. PMID: 22826442 Review.
-
Clearing the path for MPN therapy monitoring.Blood. 2013 Nov 28;122(23):3704-5. doi: 10.1182/blood-2013-10-529990. Blood. 2013. PMID: 24288406 No abstract available.
-
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.Cancer. 2019 Jun 1;125(11):1855-1866. doi: 10.1002/cncr.31986. Epub 2019 Feb 27. Cancer. 2019. PMID: 30811597
-
Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?Cerebrovasc Dis. 2017;44(3-4):97-104. doi: 10.1159/000471891. Epub 2017 Jun 14. Cerebrovasc Dis. 2017. PMID: 28609766
-
JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy.Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):110-117. doi: 10.1182/asheducation-2018.1.110. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504299 Free PMC article. Review.
Cited by
-
Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.Int J Mol Sci. 2021 Jan 11;22(2):659. doi: 10.3390/ijms22020659. Int J Mol Sci. 2021. PMID: 33440869 Free PMC article. Review.
-
Novel targeted therapies of T cell lymphomas.J Hematol Oncol. 2020 Dec 31;13(1):176. doi: 10.1186/s13045-020-01006-w. J Hematol Oncol. 2020. PMID: 33384022 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
